Zymergen (ZY) Stock Analysis

What Zymergen does

Zymergen Inc. specializes in the creation, advancement, and market introduction of various biological entities and substances, including microorganisms, specialized molecules, and novel materials. The company provides an advanced automation platform, which incorporates adaptable automation carts—modular hardware components enabling the construction of laboratory work cells tailored to specific research requirements. Additionally, it features cloud-based automation control software designed to manage integrated automated systems efficiently. Zymergen's diverse clientele spans sectors such as electronics, packaging, healthcare, agriculture, and others. Established in 2013, Zymergen Inc. is headquartered in Emeryville, California. Since October 19, 2022, the company has operated as a subsidiary under Ginkgo Bioworks Holdings, Inc.

Key metrics

ETFs linked to ZY

Broad-market and Basic Materials sector ETFs an investor holding Zymergen is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how ZY fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Frequently asked questions

What is the ticker symbol for Zymergen?

Zymergen trades under the ticker ZY on NASDAQ.

Which exchange is ZY listed on?

ZY is listed on NASDAQ.

What sector does Zymergen operate in?

Zymergen is classified in the Basic Materials sector (Chemicals - Specialty industry).

How can PortView help analyze ZY in a portfolio?

PortView shows ZY's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.